Editas Medicine (EDIT) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free EDIT Stock Alerts $5.46 -0.14 (-2.50%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Editas Medicine Stock Price Performance5 Day Performance-1.62%1 Month Performance-26.91%3 Month Performance-34.53%6 Month Performance-12.64%Year-To-Date Performance-46.10%1 Year Performance-33.25% Receive EDIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. EDIT Stock Chart for Tuesday, April, 23, 2024 EDIT Chart by TradingView Editas Medicine Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$5.60$5.46-2.50%$5.92$5.461.64 million shs$449.03 million04/22/2024$5.49$5.60+2.00%$5.79$5.391.74 million shs$460.54 million04/19/2024$5.55$5.49-1.08%$5.68$5.292.26 million shs$451.50 million04/18/2024$5.61$5.55-1.07%$5.68$5.511.71 million shs$454.05 million04/17/2024$5.85$5.61-4.10%$5.90$5.601.91 million shs$458.95 million04/16/2024$6.08$5.85-3.78%$6.03$5.851.34 million shs$478.59 million Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$6.21$6.08-2.09%$6.29$5.981.77 million shs$497.41 million04/12/2024$6.58$6.21-5.62%$6.53$6.132.02 million shs$508.04 million04/11/2024$6.63$6.58-0.75%$6.77$6.441.48 million shs$538.31 million04/10/2024$7.01$6.63-5.42%$6.80$6.542.13 million shs$542.40 million04/09/2024$6.72$7.01+4.32%$7.03$6.671.57 million shs$573.49 million04/08/2024$6.72$6.72$6.87$6.681.04 million shs$549.76 million04/05/2024$6.81$6.72-1.32%$6.85$6.651.25 million shs$549.79 million04/04/2024$6.86$6.81-0.73%$7.08$6.772.09 million shs$557.13 million04/03/2024$6.87$6.86-0.15%$7.02$6.651.81 million shs$561.22 million04/02/2024$7.28$6.87-5.63%$7.13$6.862.22 million shs$562.04 million04/01/2024$7.42$7.28-1.89%$7.41$7.151.25 million shs$595.58 million03/29/2024$7.42$7.42$7.52$7.371.56 million shs$607.03 million03/28/2024$7.44$7.42-0.27%$7.52$7.371.56 million shs$607.03 million03/27/2024$7.22$7.44+3.05%$7.53$7.191.28 million shs$608.67 million03/26/2024$7.36$7.22-1.90%$7.59$7.201.85 million shs$590.67 million03/25/2024$7.47$7.36-1.47%$7.59$7.321.17 million shs$602.15 million03/22/2024$7.83$7.47-4.60%$7.78$7.441.27 million shs$611.12 million03/21/2024$7.92$7.83-1.14%$8.44$7.811.99 million shs$640.57 million03/20/2024$7.75$7.92+2.19%$8.12$7.592.35 million shs$647.97 million03/19/2024$7.72$7.75+0.39%$7.98$7.601.99 million shs$634.03 million03/18/2024$8.13$7.72-5.04%$8.12$7.702.66 million shs$631.57 million03/15/2024$8.15$8.13-0.25%$8.31$8.066.64 million shs$665.12 million03/14/2024$8.59$8.15-5.12%$8.58$8.071.47 million shs$666.75 million03/13/2024$8.61$8.59-0.23%$8.86$8.491.33 million shs$702.75 million03/12/2024$9.00$8.61-4.33%$9.08$8.591.46 million shs$704.38 million03/11/2024$9.16$9.00-1.75%$9.60$8.911.60 million shs$736.33 million03/08/2024$8.85$9.16+3.50%$9.33$8.791.69 million shs$749.38 million03/07/2024$9.08$8.85-2.53%$9.34$8.692.19 million shs$724.02 million03/06/2024$9.14$9.08-0.66%$9.41$8.951.87 million shs$742.87 million03/05/2024$9.92$9.14-7.86%$9.95$9.052.41 million shs$747.74 million03/04/2024$10.53$9.92-5.79%$10.73$9.771.96 million shs$811.56 million03/01/2024$10.06$10.53+4.67%$11.06$9.972.62 million shs$859.99 million02/29/2024$11.07$10.06-9.12%$11.38$10.023.87 million shs$821.60 million02/28/2024$8.86$11.07+24.94%$11.58$9.587.17 million shs$904.09 millionPutin and other countries have a plan (Ad)Did you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy02/27/2024$8.06$8.86+9.93%$9.02$8.153.20 million shs$723.60 million02/26/2024$7.81$8.06+3.20%$8.17$7.751.50 million shs$658.26 million02/23/2024$7.93$7.81-1.51%$7.91$7.681.05 million shs$637.84 million02/22/2024$8.01$7.93-1.00%$8.13$7.791.57 million shs$647.64 million02/21/2024$7.95$8.01+0.75%$8.10$7.621.20 million shs$654.21 million02/20/2024$8.15$7.95-2.45%$8.23$7.821.29 million shs$649.28 million02/19/2024$8.15$8.15$8.24$8.041.27 million shs$665.61 million02/16/2024$8.31$8.15-1.93%$8.24$8.041.27 million shs$665.64 million02/15/2024$7.92$8.31+4.92%$8.48$7.992.00 million shs$678.68 million02/14/2024$7.40$7.92+7.03%$7.94$7.542.00 million shs$646.83 million02/13/2024$8.13$7.40-8.98%$7.76$7.332.42 million shs$604.36 million02/12/2024$7.45$8.13+9.13%$8.15$7.382.00 million shs$663.98 million02/09/2024$7.17$7.45+3.91%$7.48$7.151.41 million shs$608.44 million02/08/2024$7.11$7.17+0.84%$7.29$7.011.47 million shs$585.57 million02/07/2024$7.21$7.11-1.39%$7.18$6.971.61 million shs$580.67 million02/06/2024$7.08$7.21+1.84%$7.28$6.921.62 million shs$588.87 million02/05/2024$7.11$7.08-0.42%$7.13$6.911.19 million shs$578.22 million02/02/2024$7.22$7.11-1.52%$7.17$6.881.20 million shs$580.67 million02/01/2024$7.03$7.22+2.70%$7.28$6.971.27 million shs$589.66 million01/31/2024$7.21$7.03-2.50%$7.45$7.021.29 million shs$574.14 million01/30/2024$7.63$7.21-5.50%$7.52$7.171.40 million shs$588.84 million01/29/2024$7.29$7.63+4.66%$7.65$6.951.68 million shs$623.14 million01/26/2024$7.78$7.29-6.30%$7.93$7.262.17 million shs$595.37 million01/25/2024$8.04$7.78-3.23%$8.18$7.741.57 million shs$635.39 million01/24/2024$8.34$8.04-3.60%$8.51$8.001.53 million shs$656.63 million01/23/2024$8.33$8.34+0.12%$8.52$8.171.39 million shs$681.13 million01/22/2024$8.09$8.33+2.97%$8.49$8.141.86 million shs$680.34 million Related Companies: Taysha Gene Therapies Stock Chart C4 Therapeutics Stock Chart Tourmaline Bio Stock Chart Alector Stock Chart Exscientia Stock Chart Replimune Group Stock Chart Voyager Therapeutics Stock Chart Fate Therapeutics Stock Chart Mesoblast Stock Chart Ocugen Stock Chart Receive EDIT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EDIT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.